Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis
<p>Abstract</p> <p>Background</p> <p>mRNAs are highly versatile, non-toxic molecules that are easy to produce and store, which can allow transient protein expression in all cell types. The safety aspects of mRNA-based treatments in gene therapy make this molecule one of...
Main Authors: | Silva Aristóbolo M, Gembre Ana F, Rossetti Renata AM, Fontoura Isabela C, Malardo Thiago, Lousada Ricardo L, Almeida Luciana P, Rocha Carolina D, Trombone Ana PF, Lorenzi Julio CC, Silva Celio L, Coelho-Castelo Arlete AM |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | BMC Biotechnology |
Online Access: | http://www.biomedcentral.com/1472-6750/10/77 |
Similar Items
-
Low-dose plasmid DNA treatment increases plasma vasopressin and regulates blood pressure in experimental endotoxemia
by: Malardo Thiago, et al.
Published: (2012-11-01) -
Antigen-presenting cells transfected with Hsp65 messenger RNA fail to treat experimental tuberculosis
by: C.D. Rocha, et al.
Published: (2012-12-01) -
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes
by: Silva Célio L, et al.
Published: (2008-07-01) -
B cells expressing IL-10 mRNA modulate memory T cells after DNA-Hsp65 immunization
by: I. C. Fontoura, et al.
Published: (2015-09-01) -
B cells expressing IL-10 mRNA modulate memory T cells after DNA-Hsp65 immunization
by: I. C. Fontoura, et al.
Published: (2015-12-01)